Outset Medical, Inc.
OM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -12.8% | 13% | 12.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 33.9% | 22.2% | 15.5% | 7.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -86.1% | -118% | -132.4% | -121.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -112.6% | -132.5% | -141.2% | -128.6% |
| EPS Diluted | -2.46 | -3.48 | -3.38 | -2.89 |
| % Growth | 29.3% | -3% | -17% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |